|
|
SFX by Ex Libris Inc. |
Contains information about title and source of a journal
Naslov: |
Opening Up Opportunities in 2023: Bio/pharma has evolved and adapted to a variety of challenges in 2022, but what might be on the cards for the industry in 2023? |
Vir: |
|
|
|
|
List of services to meet your request
Contains list of services for current record
Basic services |
|
|
Dodatne storitve |
|
|
© 2024 SFX by Ex Libris Inc. | Politika piškotkov
CrossRef Omogočeno
|